Increase Your Understanding of GMP Water and Steam Systems
ISPE Updates Guide to include Key Concepts of a Global Implementation
Pharmaceutical water and clean (pure) steam are used as utilities and ingredients for Good ManufacturingPractice (GMP) processes, which produce drug products and drug substances such as Active Pharmaceutical Ingredients (APIs). In addition, water may be used as a final product, such as USP packaged waters.
Commissioning and qualification brings the water or steam system into operation, through the design and construction project phases and verifies that these GMP systems (equipment and controls) create product (water and steam) with a consistent and repeatable quality. Qualification also verifies that supporting quality systems have been integrated into the validation life cycle to\ maintain the validated state.
The ISPE Good Practice Guide: Commissioning and Qualification of Pharmaceutical Water and Steam Systems provides a complementary approach on how commissioning and qualification correspond and relate to the validation life cycle risk management, PAT and QbD. In addition, the Guide aims to provide alternative approaches for the validation of water and steam systems that undergo commissioning and qualification. Key concepts and principles addressed in the revision include the validation life cycle, critical components, non-critical components, and impact assessment.
Ultimately, the goal is to increase understanding of GMP water and steam systems in the pharmaceutical and biotechnology industries. Although there are a number of ways of achieving this goal, ISPE’s Guide describes one example of how to implement a science and risk-based approach.
Discussion is centered on those items which directly affect water or steam quality attributes during production, storage, and distribution.
A record-setting 640 attendees gathered in Rome in March for the 2018 ISPE Europe Annual Conference. More than 70 sessions offered the latest thinking on topics including facilities of the future, digitization, mass serialization, and the need for data...
MTF is a supplier of Allograft – bone and dermal tissue. The purpose of this isolator project involves the production of Demineralized Bone Matrix (DBX) putty. DBX putty is processed human bone that has been demineralized and combined with sodium...
Gilead Science’s 28 August purchase of Kite Pharma, Inc., one of the companies developing CAR T-cells, a therapy that harnesses the body’s own immune system to recognize and attack malignant cells, paid off in spades last week. On Wednesday, 18 October,...